Integrated BioPharma, Inc. (OTCMKTS:INBP – Get Free Report)’s stock price was down 7.1% on Monday . The company traded as low as $0.33 and last traded at $0.33. Approximately 11,630 shares traded hands during trading, a decline of 31% from the average daily volume of 16,847 shares. The stock had previously closed at $0.35.
Integrated BioPharma Stock Performance
The stock has a market cap of $9.85 million, a P/E ratio of 16.26 and a beta of 0.59. The firm’s fifty day simple moving average is $0.32 and its 200-day simple moving average is $0.26.
About Integrated BioPharma
Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.
See Also
- Five stocks we like better than Integrated BioPharma
- How Technical Indicators Can Help You Find Oversold Stocks
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- The 3 Best Fintech Stocks to Buy Now
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- 3 Warren Buffett Stocks to Buy Now
- Delta Can Fly to New Highs in 2025; Here’s Why
Receive News & Ratings for Integrated BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
